Literature DB >> 22987503

ATP conditions intestinal epithelial cells to an inflammatory state that promotes components of DC maturation.

Yu Yao1, Megan K Levings, Theodore S Steiner.   

Abstract

Intestinal epithelial cells (IECs) normally promote the development of gut resident tolerogenic dendritic cells (DCs) and regulatory T cells, but how this process is altered in inflammatory bowel disease is not well characterized. Recently, we published that the cell injury signal ATP modulates IEC chemokine responses to the TLR5 ligand flagellin and exacerbates colitis in the presence of flagellin. We hypothesized that ATP switches these IECs from tolerogenic to proinflammatory, enhancing DC activation and immune responses to commensal antigens. Here, we report that ATP enhanced murine IEC production of KC, IL-6, TGF-β, and thymic stromal lymphopoietin in response to TLR1/2 stimulation by Pam(3) CSK(4) (PAM). Moreover, supernatants from IECs stimulated with ATP+PAM enhanced expression of CD80 on bone marrow derived dendritic cells, and increased their production of IL-12, IL-6, IL-23, TGF-β, and aldh1a2, suggesting a Th1/Th17 polarizing environment. DCs conditioned by stressed IECs stimulated an enhanced recall response to flagellin and supported the expansion of IFN-γ(+) and IL-17(+) memory T cells. Lastly, colonic administration of nonhydrolysable ATP increased production of IL-6 and Cxcl1 (KC) by IECs. These findings indicate that ATP influences the response of IECs to TLR ligands and biases the maturation of DCs to become inflammatory.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22987503     DOI: 10.1002/eji.201142213

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

Review 1.  Development and survival of Th17 cells within the intestines: the influence of microbiome- and diet-derived signals.

Authors:  Joseph H Chewning; Casey T Weaver
Journal:  J Immunol       Date:  2014-11-15       Impact factor: 5.422

Review 2.  Pathophysiological role of extracellular purinergic mediators in the control of intestinal inflammation.

Authors:  Yosuke Kurashima; Hiroshi Kiyono; Jun Kunisawa
Journal:  Mediators Inflamm       Date:  2015-04-07       Impact factor: 4.711

3.  Killed Whole-Cell Oral Cholera Vaccine Induces CCL20 Secretion by Human Intestinal Epithelial Cells in the Presence of the Short-Chain Fatty Acid, Butyrate.

Authors:  Ju-Ri Sim; Seok-Seong Kang; Daesang Lee; Cheol-Heui Yun; Seung Hyun Han
Journal:  Front Immunol       Date:  2018-01-29       Impact factor: 7.561

4.  Adenosine Triphosphate Promotes Allergen-Induced Airway Inflammation and Th17 Cell Polarization in Neutrophilic Asthma.

Authors:  Fang Zhang; Xin Su; Gang Huang; Xiao-Feng Xin; E-Hong Cao; Yi Shi; Yong Song
Journal:  J Immunol Res       Date:  2017-05-25       Impact factor: 4.818

5.  Histological and toxicological evaluation, in rat, of a P-glycoprotein inducer and activator: 1-(propan-2-ylamino)-4-propoxy-9H-thioxanthen-9-one (TX5).

Authors:  Carolina Rocha-Pereira; Vera Silva; Vera Marisa Costa; Renata Silva; Juliana Garcia; Salomé Gonçalves-Monteiro; Margarida Duarte-Araújo; Alice Santos-Silva; Susana Coimbra; Ricardo Jorge Dinis-Oliveira; Catarina Lopes; Paula Silva; Solida Long; Emília Sousa; Maria de Lourdes Bastos; Fernando Remião
Journal:  EXCLI J       Date:  2019-08-27       Impact factor: 4.068

6.  The flagellin of candidate live biotherapeutic Enterococcus gallinarum MRx0518 is a potent immunostimulant.

Authors:  Delphine L Lauté-Caly; Emma J Raftis; Philip Cowie; Emma Hennessy; Amy Holt; D Alessio Panzica; Christina Sparre; Beverley Minter; Eline Stroobach; Imke E Mulder
Journal:  Sci Rep       Date:  2019-01-28       Impact factor: 4.379

Review 7.  The Effect of the Tumor Microenvironment and Tumor-Derived Metabolites on Dendritic Cell Function.

Authors:  Jun-Ho Lee; So-Yeon Choi; Nam-Chul Jung; Jie-Young Song; Han Geuk Seo; Hyun Soo Lee; Dae-Seog Lim
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.207

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.